Lederle Laboratories is a 23 MW Natural Gas Fired Combined Cycle asset in NYISO (New York), currently Operating.
Lederle Laboratories is reported in New York since 1990 under Veolia NA - Municipal & Commercial Business. Available operating and financial measures include 72.8% capacity factor and 149 GWh annual generation; $965/kW reported CapEx.
- Location
- Rockland, New York
- Technology
- Natural Gas Fired Combined Cycle
- Owner / parent
- Veolia NA - Municipal & Commercial Business
- Operator
- Veolia NA - Municipal & Commercial Business
- Grid
- NYISO (New York)
- Plant ID
- 10521
What stands out
Lederle Laboratories is a 23 MW Natural Gas Fired Combined Cycle asset in New York with status Operating.
Latest annual operating measures report 72.8% capacity factor and 149 GWh annual generation.
Available financial measures include $965/kW CapEx.
Latest linked story: “Lederle Gets First U.S. Patent For a 'Live' Anti-Polio Vaccine; Wide Variety of Ideas Covered By Patents Issued During Week (Published 1960)” (The New York Times, 2018-03-19).
Market and operating context
- ISO / market
- NYISO (New York)
- Balancing authority
- New York Independent System Operator
- NERC region
- NPCC
- State rank
- #70 of 103
- National rank
- #1326 of 2,025
Why it matters
For this asset in NYISO (New York), operating status, generation, ownership, and linked events are the primary facts for performance and asset-level diligence. The exact chart and source-linked records below let the reader test those facts before moving to a deeper report.
